Conveners
S33 Redefining Cancer Modeling: Patient-Derived Organoids Enabled by Extracellular Matrix (ECM)-Inspired Scaffolds
- Désirée Baruffaldi (Department of Applied Science and Technology, PolitoBIOMed Lab, Politecnico di Torino)
- Andrea Cosola (Department of Applied Science and Technology, PolitoBIOMed Lab, Politecnico di Torino)
-
Maria Giovanna Francipane16/09/2025, 11:00invited lecture
Biliary complications, such as post-operative biliary strictures, pose serious health risks and place a significant burden on healthcare systems. Conventional treatments, including plastic stents, require frequent replacement, while self-expanding metal stents, despite longer patency, carry risks such as migration and tissue ingrowth. Biodegradable scaffolds offer a promising alternative due...
Go to contribution page -
Valentina Monica16/09/2025, 11:20invited lecture
In the last twenty years, the systemic cytotoxic chemotherapy approach left gradually place to a more personalized clinical concept, aiming to identify and target tumor peculiarities which make one tumor different from another. The lack of coherence between experimental results and in vivo effectiveness confirmed the limitation of using clonal 2D cell cultures to predict the efficacy of...
Go to contribution page -
Nicole Fratini (Sapienza University)16/09/2025, 11:40podium presentation
Introduction
Go to contribution page
Ovarian cancer (OC) is the leading cause of death among gynecological malignancies, primarily due to its high mortality rate and frequent recurrence. The standard treatment, platinum-based chemotherapy, often becomes ineffective as patients develop platinum resistance, a process associated with enhanced metastatic potential, epithelial-mesenchymal transition (EMT), and... -
Pragati Sharma (Indian Institute of Technology Hyderabad)16/09/2025, 11:50podium presentation
Transforming Pre-Clinical Drug Testing: 3D Bioprinted Patient-Derived Breast Cancer Models on a Microfluidic Device
Go to contribution page
Pragati Sharma1 and Subha Narayan Rath1
1Regenerative Medicine and Stem Cell Laboratory (RMS), Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Sangareddy 502284, Telangana, India.
Correspondence: Subha Narayan Rath, Email:... -
Giorgia Savino (Politecnico di Torino)16/09/2025, 12:00podium presentation
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Nanomedicine has shown significant potential in enhancing treatment outcomes and in overcoming the limitation of traditional therapeutic approaches. However, a major challenge lies in translating these advancements into clinical applications. To bridge this gap, we propose a 3D bioprinted model that mimics CRC...
Go to contribution page -
Jan Guzowski (Institute of Physical Chemistry Polish Academy of Sciences)16/09/2025, 12:10podium presentation
The available methods of reproducible formulation of human tumor microenvironments (hTMEs) that is micro-engineered systems incorporating cancer, stroma and extracellular matrix (ECM), that could serve as preclinical models of disease, e.g., in anti-cancer drug testing, currently suffer from excessive complexity (organ-on-chip systems) and/or low-throughput (3D bioprinted constructs). Here, we...
Go to contribution page -
Seo Hyeon An (Sungkyunkwan University School of Medicine (SKKU-SOM))16/09/2025, 12:20podium presentation
Glioblastoma (GBM) is a highly invasive and heterogeneous brain tumor, making it particularly difficult to replicate its complex tumor microenvironment (TME) in vitro. One promising approach involves using GBM-derived decellularized extracellular matrices (dECMs), which closely mimic the native TME. These dECMs contain tumor-specific biochemical components such as glioma-associated...
Go to contribution page